Bupropion hydrochloride, a norepinephrine and dopamine reuptake inhibitor, is a highly permeable and soluble compound primarily used for major depressive disorder (MDD) treatment and smoking cessation. Metabolized in the liver via CYP2B6, it forms 6-hydroxybupropion, the major active metabolite, along with 4′-hydroxybupropion, threohydrobupropion, and erythrohydrobupropion. These metabolites play vital roles in its therapeutic effects. Marketed under various brands and generics, bioequivalence for these products is assessed using FDA-recommended pharmacokinetic (PK) studies. Innovations like PBPK modeling integrate drug properties, patient physiology, and metabolism to predict performance, supporting drug development and regulatory decisions.
Hsieh, N.-H., Bois, F.Y., Tsakalozou, E., Ni, Z., Yoon, M., Sun, W., Klein, M., Reisfeld, B., & Chiu, W.A. (2021) A Bayesian Population Physiologically Based Pharmacokinetic Absorption Modeling Approach to Support Generic Drug Development: Application to Bupropion Hydrochloride Oral Dosage Forms, J Pharmacokinet Pharmacodyn.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For more details consult with your doctor or healthcare professional.
Hsieh, N.-H., Bois, F.Y., Tsakalozou, E., Ni, Z., Yoon, M., Sun, W., Klein, M., Reisfeld, B., & Chiu, W.A. (2021) A Bayesian Population Physiologically Based Pharmacokinetic Absorption Modeling Approach to Support Generic Drug Development: Application to Bupropion Hydrochloride Oral Dosage Forms, J Pharmacokinet Pharmacodyn.
Hsieh, N.-H., Bois, F.Y., Tsakalozou, E., Ni, Z., Yoon, M., Sun, W., Klein, M., Reisfeld, B., & Chiu, W.A. (2021) A Bayesian Population Physiologically Based Pharmacokinetic Absorption Modeling Approach to Support Generic Drug Development: Application to Bupropion Hydrochloride Oral Dosage Forms, J Pharmacokinet Pharmacodyn.
Hsieh, N.-H., Bois, F.Y., Tsakalozou, E., Ni, Z., Yoon, M., Sun, W., Klein, M., Reisfeld, B., & Chiu, W.A. (2021) A Bayesian Population Physiologically Based Pharmacokinetic Absorption Modeling Approach to Support Generic Drug Development: Application to Bupropion Hydrochloride Oral Dosage Forms, J Pharmacokinet Pharmacodyn.